Tens of thousands of injury victims could be saved each year from bleeding to death, according to research just released in the medical journal: The Lancet. Scientist studying 20 000 patients taking part in the CRASH-2 trial in 274 hospitals in 40 countries have found that a simple, cheap, drug – normally used to stem the flow of blood during surgery – could save as many as 100 000 lives each year among the more than half a million victims of injury around the world. Scientists Ian Roberts from the London School of Hygiene and Tropical Medicine, and Tim Coats from Leicester University, gave a press briefing in London – together with anaesthetist Jorge Mejia from Colombia and the Director of the World Health Organisation’s Department for Violence and Injury Prevention and Disability, Etienne Krug – to discuss the importance of the CRASH-2 findings in terms of saving lives at low cost around the world. Ian Roberts tells Peter Goodwin more about why these findings are important for emergency medicine around the world.
LISTEN
[audio:https://www.audiomedica.com/podcasting/lshtm/CRASH_2_Study_Podcast.mp3]
